Share Price and Basic Stock Data
Last Updated: January 3, 2026, 12:44 pm
| PEG Ratio | 1.06 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Vadilal Industries Ltd operates in the Milk & Milk Products sector, reporting a current market capitalization of ₹3,496 Cr and a share price of ₹4,862. The company has shown a substantial growth trajectory in its revenue, with sales rising from ₹367 Cr in March 2014 to ₹1,326 Cr for the trailing twelve months (TTM). This growth reflects a compounded annual growth rate (CAGR) of approximately 18%, showcasing the company’s ability to capture market demand effectively. In FY 2025, sales stood at ₹1,238 Cr, up from ₹1,125 Cr in FY 2024, indicating a consistent upward trend. Quarterly sales figures also reflect volatility, with the latest quarter (September 2023) recording sales of ₹289 Cr, following a robust ₹411 Cr in June 2023. This fluctuation suggests seasonal impacts or changes in consumer preferences that the company must navigate to maintain its growth momentum.
Profitability and Efficiency Metrics
Vadilal Industries reported a net profit of ₹134 Cr for the TTM, with an impressive return on equity (ROE) of 24% and return on capital employed (ROCE) at 25.1%. The operating profit margin (OPM) for FY 2025 was recorded at 19%, reflecting a healthy profitability level, though slightly lower than the 20% OPM reported in FY 2024. The company’s interest coverage ratio (ICR) at 18.68x signifies strong ability to meet interest obligations, indicating financial robustness. However, the cash conversion cycle (CCC) of 143 days suggests inefficiencies in managing working capital, particularly when compared to industry norms where lower CCC is generally preferred. The company’s ability to convert sales into cash efficiently will be crucial for sustaining profitability and funding future growth initiatives.
Balance Sheet Strength and Financial Ratios
The balance sheet of Vadilal Industries indicates a stable financial position, with total assets amounting to ₹1,156 Cr and total borrowings at ₹204 Cr. The debt-to-equity ratio stands at 0.13, reflecting a low level of financial leverage and a conservative approach to financing. With reserves reported at ₹778 Cr, the company has a solid buffer to weather economic fluctuations. The current ratio of 2.56 signifies a strong liquidity position, well above the typical threshold of 1.5, allowing the company ample coverage for short-term liabilities. However, the price-to-book value (P/BV) ratio of 5.33x indicates that the stock may be overvalued compared to its book value, which could raise concerns among value investors. The company must ensure that its operational performance justifies this valuation to maintain investor confidence.
Shareholding Pattern and Investor Confidence
Vadilal Industries has a diverse shareholding structure, with promoters holding a significant 64.72% stake, suggesting strong control over the company’s strategic direction. The public holds 34.23%, while foreign institutional investors (FIIs) and domestic institutional investors (DIIs) account for 0.57% and 0.47%, respectively. The number of shareholders has increased from 12,487 in December 2022 to 19,638 by September 2025, indicating growing investor interest. However, the limited foreign and institutional investment may restrict broader market acceptance and liquidity. Maintaining a steady dividend payout ratio of 10% in FY 2025 reflects a commitment to returning value to shareholders, which can further enhance investor confidence. The stable promoter holding paired with a rising shareholder base bodes well for the company’s governance and future growth potential.
Outlook, Risks, and Final Insight
The outlook for Vadilal Industries appears positive, given its strong revenue growth and profitability metrics. The company’s ability to innovate and adapt to changing consumer preferences in the milk and dairy sector will be critical for sustaining this momentum. However, risks such as fluctuating raw material costs and potential supply chain disruptions could impact profitability. Additionally, the high cash conversion cycle indicates room for improvement in operational efficiency. If Vadilal can enhance its working capital management, it may unlock further profitability. Conversely, any significant deviations in market demand or adverse economic conditions could pose challenges. Overall, with prudent management and strategic initiatives, Vadilal Industries is well-positioned to capitalize on growth opportunities while mitigating inherent risks in the dairy industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Modern Dairies Ltd | 94.6 Cr. | 36.9 | 68.9/34.1 | 4.08 | 17.0 | 0.00 % | % | % | 10.0 |
| Healthy Life Agritec Ltd | 59.9 Cr. | 12.1 | 61.2/11.8 | 16.2 | 7.25 | 0.00 % | 13.3 % | 10.6 % | 10.0 |
| Dodla Dairy Ltd | 7,362 Cr. | 1,220 | 1,525/962 | 28.3 | 254 | 0.41 % | 26.6 % | 19.8 % | 10.0 |
| Vadilal Industries Ltd | 3,496 Cr. | 4,862 | 7,399/3,411 | 26.0 | 1,092 | 0.43 % | 25.1 % | 24.0 % | 10.0 |
| Umang Dairies Ltd | 189 Cr. | 85.7 | 106/67.0 | 309 | 20.7 | 0.00 % | 4.52 % | 1.35 % | 5.00 |
| Industry Average | 7,420.00 Cr | 1,093.96 | 67.04 | 226.64 | 0.28% | 17.99% | 15.49% | 7.29 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 267 | 143 | 256 | 411 | 289 | 174 | 251 | 464 | 296 | 204 | 274 | 506 | 341 |
| Expenses | 223 | 149 | 208 | 307 | 230 | 163 | 206 | 351 | 235 | 178 | 236 | 406 | 290 |
| Operating Profit | 44 | -6 | 49 | 104 | 59 | 11 | 46 | 113 | 61 | 26 | 39 | 100 | 51 |
| OPM % | 17% | -4% | 19% | 25% | 20% | 6% | 18% | 24% | 20% | 13% | 14% | 20% | 15% |
| Other Income | 4 | 4 | 2 | 2 | 4 | 4 | 3 | 4 | 5 | 4 | 3 | 5 | 7 |
| Interest | 3 | 4 | 5 | 6 | 4 | 4 | 4 | 4 | 3 | 3 | 4 | 4 | 4 |
| Depreciation | 8 | 6 | 8 | 9 | 9 | 8 | 9 | 11 | 11 | 10 | 11 | 12 | 12 |
| Profit before tax | 37 | -12 | 38 | 92 | 50 | 3 | 35 | 103 | 52 | 17 | 27 | 89 | 43 |
| Tax % | 27% | -22% | 24% | 23% | 24% | -210% | 21% | 25% | 25% | 31% | 19% | 25% | 23% |
| Net Profit | 27 | -9 | 29 | 71 | 38 | 9 | 28 | 77 | 39 | 12 | 22 | 67 | 33 |
| EPS in Rs | 38.02 | -12.92 | 40.04 | 98.81 | 52.94 | 12.86 | 38.45 | 107.71 | 54.23 | 16.60 | 30.61 | 93.19 | 46.50 |
Last Updated: December 28, 2025, 3:32 pm
Below is a detailed analysis of the quarterly data for Vadilal Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 341.00 Cr.. The value appears to be declining and may need further review. It has decreased from 506.00 Cr. (Jun 2025) to 341.00 Cr., marking a decrease of 165.00 Cr..
- For Expenses, as of Sep 2025, the value is 290.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 406.00 Cr. (Jun 2025) to 290.00 Cr., marking a decrease of 116.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 51.00 Cr.. The value appears to be declining and may need further review. It has decreased from 100.00 Cr. (Jun 2025) to 51.00 Cr., marking a decrease of 49.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 20.00% (Jun 2025) to 15.00%, marking a decrease of 5.00%.
- For Other Income, as of Sep 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Jun 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 4.00 Cr..
- For Depreciation, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 12.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 89.00 Cr. (Jun 2025) to 43.00 Cr., marking a decrease of 46.00 Cr..
- For Tax %, as of Sep 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Jun 2025) to 23.00%, marking a decrease of 2.00%.
- For Net Profit, as of Sep 2025, the value is 33.00 Cr.. The value appears to be declining and may need further review. It has decreased from 67.00 Cr. (Jun 2025) to 33.00 Cr., marking a decrease of 34.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 46.50. The value appears to be declining and may need further review. It has decreased from 93.19 (Jun 2025) to 46.50, marking a decrease of 46.69.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:26 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 367 | 406 | 450 | 482 | 547 | 567 | 599 | 463 | 698 | 1,058 | 1,125 | 1,238 | 1,326 |
| Expenses | 327 | 367 | 391 | 425 | 499 | 494 | 521 | 428 | 599 | 892 | 904 | 999 | 1,110 |
| Operating Profit | 40 | 39 | 58 | 57 | 48 | 73 | 79 | 36 | 99 | 166 | 221 | 239 | 215 |
| OPM % | 11% | 10% | 13% | 12% | 9% | 13% | 13% | 8% | 14% | 16% | 20% | 19% | 16% |
| Other Income | 2 | 3 | 1 | 3 | 6 | 10 | 10 | 16 | 8 | 10 | 12 | 17 | 20 |
| Interest | 25 | 26 | 21 | 16 | 15 | 14 | 17 | 21 | 19 | 16 | 18 | 14 | 15 |
| Depreciation | 13 | 13 | 14 | 15 | 16 | 17 | 24 | 23 | 24 | 30 | 35 | 42 | 44 |
| Profit before tax | 4 | 4 | 24 | 29 | 23 | 52 | 48 | 8 | 64 | 131 | 180 | 200 | 177 |
| Tax % | 36% | 36% | 40% | 35% | 32% | 36% | 14% | 40% | 30% | 26% | 19% | 25% | |
| Net Profit | 2 | 2 | 15 | 19 | 16 | 33 | 41 | 5 | 45 | 96 | 146 | 150 | 134 |
| EPS in Rs | 3.20 | 3.39 | 20.53 | 26.52 | 21.79 | 46.41 | 57.57 | 6.44 | 62.19 | 133.96 | 203.05 | 209.15 | 186.90 |
| Dividend Payout % | 31% | 29% | 6% | 5% | 6% | 3% | 0% | 0% | 2% | 1% | 1% | 10% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 0.00% | 650.00% | 26.67% | -15.79% | 106.25% | 24.24% | -87.80% | 800.00% | 113.33% | 52.08% | 2.74% |
| Change in YoY Net Profit Growth (%) | 0.00% | 650.00% | -623.33% | -42.46% | 122.04% | -82.01% | -112.05% | 887.80% | -686.67% | -61.25% | -49.34% |
Vadilal Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 12% |
| 5 Years: | 16% |
| 3 Years: | 21% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 55% |
| 5 Years: | 30% |
| 3 Years: | 50% |
| TTM: | -8% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 26% |
| 5 Years: | 46% |
| 3 Years: | 25% |
| 1 Year: | 18% |
| Return on Equity | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 23% |
| 3 Years: | 27% |
| Last Year: | 24% |
Last Updated: September 5, 2025, 1:50 pm
Balance Sheet
Last Updated: December 4, 2025, 2:11 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves | 106 | 106 | 120 | 154 | 168 | 200 | 240 | 244 | 290 | 390 | 535 | 688 | 778 |
| Borrowings | 166 | 152 | 122 | 119 | 141 | 148 | 174 | 158 | 186 | 291 | 223 | 218 | 204 |
| Other Liabilities | 97 | 104 | 117 | 134 | 123 | 122 | 153 | 159 | 140 | 150 | 151 | 181 | 167 |
| Total Liabilities | 376 | 370 | 366 | 414 | 439 | 477 | 574 | 567 | 623 | 838 | 917 | 1,094 | 1,156 |
| Fixed Assets | 228 | 226 | 225 | 251 | 257 | 267 | 318 | 312 | 307 | 403 | 444 | 478 | 472 |
| CWIP | 4 | 1 | 1 | 5 | 7 | 13 | 9 | 5 | 3 | 20 | 12 | 10 | 14 |
| Investments | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 5 | 16 | 22 | 82 |
| Other Assets | 144 | 143 | 141 | 158 | 175 | 196 | 247 | 250 | 313 | 410 | 445 | 584 | 588 |
| Total Assets | 376 | 370 | 366 | 414 | 439 | 477 | 574 | 567 | 623 | 838 | 917 | 1,094 | 1,156 |
Below is a detailed analysis of the balance sheet data for Vadilal Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 7.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 7.00 Cr..
- For Reserves, as of Sep 2025, the value is 778.00 Cr.. The value appears strong and on an upward trend. It has increased from 688.00 Cr. (Mar 2025) to 778.00 Cr., marking an increase of 90.00 Cr..
- For Borrowings, as of Sep 2025, the value is 204.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 218.00 Cr. (Mar 2025) to 204.00 Cr., marking a decrease of 14.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 167.00 Cr.. The value appears to be improving (decreasing). It has decreased from 181.00 Cr. (Mar 2025) to 167.00 Cr., marking a decrease of 14.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,156.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,094.00 Cr. (Mar 2025) to 1,156.00 Cr., marking an increase of 62.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 472.00 Cr.. The value appears to be declining and may need further review. It has decreased from 478.00 Cr. (Mar 2025) to 472.00 Cr., marking a decrease of 6.00 Cr..
- For CWIP, as of Sep 2025, the value is 14.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 4.00 Cr..
- For Investments, as of Sep 2025, the value is 82.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2025) to 82.00 Cr., marking an increase of 60.00 Cr..
- For Other Assets, as of Sep 2025, the value is 588.00 Cr.. The value appears strong and on an upward trend. It has increased from 584.00 Cr. (Mar 2025) to 588.00 Cr., marking an increase of 4.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,156.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,094.00 Cr. (Mar 2025) to 1,156.00 Cr., marking an increase of 62.00 Cr..
Notably, the Reserves (778.00 Cr.) exceed the Borrowings (204.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -126.00 | -113.00 | -64.00 | -62.00 | -93.00 | -75.00 | -95.00 | -122.00 | -87.00 | -125.00 | -2.00 | 21.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 15 | 14 | 18 | 8 | 28 | 20 | 27 | 36 | 34 | 27 | 31 | 36 |
| Inventory Days | 178 | 144 | 138 | 135 | 119 | 157 | 179 | 211 | 170 | 167 | 146 | 188 |
| Days Payable | 104 | 96 | 104 | 92 | 91 | 86 | 98 | 165 | 85 | 58 | 62 | 81 |
| Cash Conversion Cycle | 89 | 62 | 51 | 51 | 56 | 91 | 107 | 81 | 119 | 135 | 115 | 143 |
| Working Capital Days | -40 | -49 | -40 | -37 | -4 | -5 | -14 | -20 | 17 | 29 | 50 | 78 |
| ROCE % | 10% | 10% | 18% | 17% | 13% | 20% | 17% | 7% | 19% | 26% | 27% | 25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 209.15 | 203.05 | 133.97 | 62.19 | 6.44 |
| Diluted EPS (Rs.) | 209.15 | 203.05 | 133.97 | 62.19 | 6.44 |
| Cash EPS (Rs.) | 267.77 | 251.54 | 175.54 | 95.54 | 38.23 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 862.41 | 650.05 | 448.45 | 309.43 | 245.06 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 967.05 | 754.70 | 553.13 | 414.11 | 349.74 |
| Revenue From Operations / Share (Rs.) | 1721.95 | 1565.13 | 1471.74 | 970.70 | 645.25 |
| PBDIT / Share (Rs.) | 355.45 | 323.74 | 245.27 | 149.13 | 72.31 |
| PBIT / Share (Rs.) | 296.76 | 275.19 | 203.70 | 115.77 | 40.52 |
| PBT / Share (Rs.) | 277.73 | 250.29 | 181.64 | 88.80 | 10.69 |
| Net Profit / Share (Rs.) | 209.08 | 202.99 | 133.97 | 62.19 | 6.44 |
| NP After MI And SOA / Share (Rs.) | 209.08 | 202.99 | 133.97 | 62.19 | 6.44 |
| PBDIT Margin (%) | 20.64 | 20.68 | 16.66 | 15.36 | 11.20 |
| PBIT Margin (%) | 17.23 | 17.58 | 13.84 | 11.92 | 6.27 |
| PBT Margin (%) | 16.12 | 15.99 | 12.34 | 9.14 | 1.65 |
| Net Profit Margin (%) | 12.14 | 12.96 | 9.10 | 6.40 | 0.99 |
| NP After MI And SOA Margin (%) | 12.14 | 12.96 | 9.10 | 6.40 | 0.99 |
| Return on Networth / Equity (%) | 24.24 | 31.24 | 29.90 | 20.12 | 2.63 |
| Return on Capital Employeed (%) | 24.01 | 28.15 | 26.02 | 20.52 | 8.69 |
| Return On Assets (%) | 13.71 | 15.91 | 11.49 | 7.17 | 0.81 |
| Long Term Debt / Equity (X) | 0.07 | 0.08 | 0.18 | 0.34 | 0.32 |
| Total Debt / Equity (X) | 0.13 | 0.25 | 0.63 | 0.77 | 0.72 |
| Asset Turnover Ratio (%) | 1.23 | 1.28 | 1.45 | 1.01 | 0.66 |
| Current Ratio (X) | 2.56 | 2.02 | 1.44 | 1.39 | 1.04 |
| Quick Ratio (X) | 1.06 | 0.95 | 0.51 | 0.63 | 0.43 |
| Inventory Turnover Ratio (X) | 4.59 | 2.05 | 2.51 | 2.33 | 1.52 |
| Dividend Payout Ratio (NP) (%) | 0.71 | 0.73 | 0.93 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 0.56 | 0.59 | 0.71 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 99.29 | 99.27 | 99.07 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 99.44 | 99.41 | 99.29 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 18.68 | 13.00 | 11.12 | 5.53 | 2.42 |
| Interest Coverage Ratio (Post Tax) (X) | 11.99 | 9.15 | 7.07 | 3.31 | 1.22 |
| Enterprise Value (Cr.) | 3345.68 | 3189.08 | 1750.95 | 1137.24 | 737.41 |
| EV / Net Operating Revenue (X) | 2.70 | 2.83 | 1.66 | 1.63 | 1.59 |
| EV / EBITDA (X) | 13.09 | 13.70 | 9.93 | 10.61 | 14.19 |
| MarketCap / Net Operating Revenue (X) | 2.67 | 2.78 | 1.50 | 1.46 | 1.39 |
| Retention Ratios (%) | 99.28 | 99.26 | 99.06 | 0.00 | 0.00 |
| Price / BV (X) | 5.33 | 6.69 | 4.92 | 4.58 | 3.67 |
| Price / Net Operating Revenue (X) | 2.67 | 2.78 | 1.50 | 1.46 | 1.39 |
| EarningsYield | 0.04 | 0.04 | 0.06 | 0.04 | 0.01 |
After reviewing the key financial ratios for Vadilal Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 209.15. This value is within the healthy range. It has increased from 203.05 (Mar 24) to 209.15, marking an increase of 6.10.
- For Diluted EPS (Rs.), as of Mar 25, the value is 209.15. This value is within the healthy range. It has increased from 203.05 (Mar 24) to 209.15, marking an increase of 6.10.
- For Cash EPS (Rs.), as of Mar 25, the value is 267.77. This value is within the healthy range. It has increased from 251.54 (Mar 24) to 267.77, marking an increase of 16.23.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 862.41. It has increased from 650.05 (Mar 24) to 862.41, marking an increase of 212.36.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 967.05. It has increased from 754.70 (Mar 24) to 967.05, marking an increase of 212.35.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 1,721.95. It has increased from 1,565.13 (Mar 24) to 1,721.95, marking an increase of 156.82.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 355.45. This value is within the healthy range. It has increased from 323.74 (Mar 24) to 355.45, marking an increase of 31.71.
- For PBIT / Share (Rs.), as of Mar 25, the value is 296.76. This value is within the healthy range. It has increased from 275.19 (Mar 24) to 296.76, marking an increase of 21.57.
- For PBT / Share (Rs.), as of Mar 25, the value is 277.73. This value is within the healthy range. It has increased from 250.29 (Mar 24) to 277.73, marking an increase of 27.44.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 209.08. This value is within the healthy range. It has increased from 202.99 (Mar 24) to 209.08, marking an increase of 6.09.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 209.08. This value is within the healthy range. It has increased from 202.99 (Mar 24) to 209.08, marking an increase of 6.09.
- For PBDIT Margin (%), as of Mar 25, the value is 20.64. This value is within the healthy range. It has decreased from 20.68 (Mar 24) to 20.64, marking a decrease of 0.04.
- For PBIT Margin (%), as of Mar 25, the value is 17.23. This value is within the healthy range. It has decreased from 17.58 (Mar 24) to 17.23, marking a decrease of 0.35.
- For PBT Margin (%), as of Mar 25, the value is 16.12. This value is within the healthy range. It has increased from 15.99 (Mar 24) to 16.12, marking an increase of 0.13.
- For Net Profit Margin (%), as of Mar 25, the value is 12.14. This value exceeds the healthy maximum of 10. It has decreased from 12.96 (Mar 24) to 12.14, marking a decrease of 0.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 12.14. This value is within the healthy range. It has decreased from 12.96 (Mar 24) to 12.14, marking a decrease of 0.82.
- For Return on Networth / Equity (%), as of Mar 25, the value is 24.24. This value is within the healthy range. It has decreased from 31.24 (Mar 24) to 24.24, marking a decrease of 7.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 24.01. This value is within the healthy range. It has decreased from 28.15 (Mar 24) to 24.01, marking a decrease of 4.14.
- For Return On Assets (%), as of Mar 25, the value is 13.71. This value is within the healthy range. It has decreased from 15.91 (Mar 24) to 13.71, marking a decrease of 2.20.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has decreased from 0.08 (Mar 24) to 0.07, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.13. This value is within the healthy range. It has decreased from 0.25 (Mar 24) to 0.13, marking a decrease of 0.12.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.23. It has decreased from 1.28 (Mar 24) to 1.23, marking a decrease of 0.05.
- For Current Ratio (X), as of Mar 25, the value is 2.56. This value is within the healthy range. It has increased from 2.02 (Mar 24) to 2.56, marking an increase of 0.54.
- For Quick Ratio (X), as of Mar 25, the value is 1.06. This value is within the healthy range. It has increased from 0.95 (Mar 24) to 1.06, marking an increase of 0.11.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.59. This value is within the healthy range. It has increased from 2.05 (Mar 24) to 4.59, marking an increase of 2.54.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.71. This value is below the healthy minimum of 20. It has decreased from 0.73 (Mar 24) to 0.71, marking a decrease of 0.02.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.56. This value is below the healthy minimum of 20. It has decreased from 0.59 (Mar 24) to 0.56, marking a decrease of 0.03.
- For Earning Retention Ratio (%), as of Mar 25, the value is 99.29. This value exceeds the healthy maximum of 70. It has increased from 99.27 (Mar 24) to 99.29, marking an increase of 0.02.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 99.44. This value exceeds the healthy maximum of 70. It has increased from 99.41 (Mar 24) to 99.44, marking an increase of 0.03.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 18.68. This value is within the healthy range. It has increased from 13.00 (Mar 24) to 18.68, marking an increase of 5.68.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 11.99. This value is within the healthy range. It has increased from 9.15 (Mar 24) to 11.99, marking an increase of 2.84.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,345.68. It has increased from 3,189.08 (Mar 24) to 3,345.68, marking an increase of 156.60.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.70. This value is within the healthy range. It has decreased from 2.83 (Mar 24) to 2.70, marking a decrease of 0.13.
- For EV / EBITDA (X), as of Mar 25, the value is 13.09. This value is within the healthy range. It has decreased from 13.70 (Mar 24) to 13.09, marking a decrease of 0.61.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.67. This value is within the healthy range. It has decreased from 2.78 (Mar 24) to 2.67, marking a decrease of 0.11.
- For Retention Ratios (%), as of Mar 25, the value is 99.28. This value exceeds the healthy maximum of 70. It has increased from 99.26 (Mar 24) to 99.28, marking an increase of 0.02.
- For Price / BV (X), as of Mar 25, the value is 5.33. This value exceeds the healthy maximum of 3. It has decreased from 6.69 (Mar 24) to 5.33, marking a decrease of 1.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.67. This value is within the healthy range. It has decreased from 2.78 (Mar 24) to 2.67, marking a decrease of 0.11.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Vadilal Industries Ltd:
- Net Profit Margin: 12.14%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 24.01% (Industry Average ROCE: 17.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 24.24% (Industry Average ROE: 15.49%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 11.99
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.06
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 26 (Industry average Stock P/E: 67.04)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.13
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 12.14%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Milk & Milk Products | Vadilal House, Shrimali Society, Nr. Navrangpura Rly. Crossing, Ahmedabad Gujarat 380009 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Shivakumar Dega | Chairman & Ind.Director |
| Mr. Janmajay V Gandhi | Executive Director |
| Mr. Shalini Raghavan | Independent Director |
| Mrs. Gaurav Marathe | Non Exe.Non Ind.Director |
| Mr. Nagarajan Sivaramakrishnan | Independent Director |
FAQ
What is the intrinsic value of Vadilal Industries Ltd?
Vadilal Industries Ltd's intrinsic value (as of 04 January 2026) is ₹5474.70 which is 12.60% higher the current market price of ₹4,862.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,496 Cr. market cap, FY2025-2026 high/low of ₹7,399/3,411, reserves of ₹778 Cr, and liabilities of ₹1,156 Cr.
What is the Market Cap of Vadilal Industries Ltd?
The Market Cap of Vadilal Industries Ltd is 3,496 Cr..
What is the current Stock Price of Vadilal Industries Ltd as on 04 January 2026?
The current stock price of Vadilal Industries Ltd as on 04 January 2026 is ₹4,862.
What is the High / Low of Vadilal Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Vadilal Industries Ltd stocks is ₹7,399/3,411.
What is the Stock P/E of Vadilal Industries Ltd?
The Stock P/E of Vadilal Industries Ltd is 26.0.
What is the Book Value of Vadilal Industries Ltd?
The Book Value of Vadilal Industries Ltd is 1,092.
What is the Dividend Yield of Vadilal Industries Ltd?
The Dividend Yield of Vadilal Industries Ltd is 0.43 %.
What is the ROCE of Vadilal Industries Ltd?
The ROCE of Vadilal Industries Ltd is 25.1 %.
What is the ROE of Vadilal Industries Ltd?
The ROE of Vadilal Industries Ltd is 24.0 %.
What is the Face Value of Vadilal Industries Ltd?
The Face Value of Vadilal Industries Ltd is 10.0.